A graphics processing unit (GPU) upgrade by Nvidia Corp is expected to drive growth in the global gaming industry this year and benefit local firms with high exposure to the sector, Yuanta Securities Investment Consulting Co (元大投顧) said in a client note on Friday.
The US chipmaker is to launch its new Ampere-based GPU in the second half of this year, leading to a rebound in demand for gaming GPUs and notebook computers after weaker-than-expected sales in the sector last year due to Nvidia digesting inventory, Yuanta said.
A successor to units based on the Turing architecture, Nvidia’s next-generation GPU based on the Ampere architecture is to adopt 7-nanometer technology, which would lead to a 50 percent increase in graphics performance while halving power consumption, the note said.
New Taipei City headquartered Micro-Star International Co (MSI, 微星科技), which makes gaming computers, graphics cards and motherboards, is expected to reap the most benefit, as 60 percent of the company’s sales come from the gaming sector, Yuanta said.
Gigabyte Technology Co Ltd (技嘉) and PC company Asustek Computer Inc (華碩) are also expected to benefit from the GPU upgrade, as about 30 percent of their revenues are rooted in the gaming business, it said.
MSI has the highest market share in the gaming business as it leads the gaming laptop market in terms of shipments ahead of Asustek, Dell Inc, Lenovo Group Ltd (聯想) and Acer Inc (宏碁), Yuanta said, citing data compiled by various research institutes.
The market for gaming laptops is expected to grow at a compound annual growth rate of 22 percent from 2016 to 2023, according to a Market Research Future report.
Asustek’s operations showed significant improvement in the second half of last year as the company’s restructuring efforts, which began in 2018, started to bear fruit, Yuanta said.
Gigabyte reported robust sales last quarter thanks to new Nvidia product launches, as well as strong server shipments.
The company’s server business is forecast to maintain a growth rate of about 20 percent this year, Yuanta said.
Yuanta issued a “buy” rating on MSI, Gigabyte and Asustek shares, with target prices of NT$112, NT$63 and NT$262 respectively.
MSI shares on Tuesday closed at NT$86.7 while Gigabyte shares were NT$49.7, having risen 13.48 percent and 23.63 percent last year respectively.
Asustek shares closed at NT$231.5, an annual gain of 14.89 percent.
The US dollar on Friday rose against the euro, but pared gains late in a session that was muddied by quarter-end trading, while riskier commodity-led currencies fell sharply after European inflation hit a record high and US consumer spending increased faster than expected. Although the dollar index was showing its biggest quarterly gain since the first quarter 2015, but was registered its first weekly decline in three weeks. Sterling rose against the dollar after falling earlier in the day. The pound last showed four straight sessions of gains followed by wild declines on concerns about Britain’s plan to slash taxes and pay
SAMSUNG DISTANT SECOND: Top local chip fims served nearly two-thirds of the global market in Q2, while Samsung kept South Korea competitive with its 16.5 percent share Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) remained the world’s largest contract chipmaker in the second quarter of the year with a 53.4 percent share of the global pure-play foundry market, the Taipei-based market information advisory firm TrendForce Corp (集邦科技) said in a research report on Tuesday. Despite TSMC’s market share dipping slightly from 53.6 percent in the first quarter, it was still far ahead of its rivals, TrendForce said. TSMC continued to benefit from emerging technologies, such as high-performance computing devices, the Internet of Things and automotive electronics, as it posted US$18.15 billion in sales in the second quarter, up 3.5 percent
Moderna Inc has refused to hand over to China the core intellectual property behind the development of its COVID-19 vaccine, leading to a collapse in negotiations on its sale in the country, the Financial Times reported on Saturday, citing people familiar with the matter. The Cambridge, Massachusetts-based pharmaceutical company turned down China’s request to disclose the formula for its mRNA vaccine because of commercial and safety concerns, the newspaper said, citing people involved in negotiations that took place from 2020 to last year, adding that the vaccine maker is still “eager” to sell the product to China. The company had “given up”
PRICE POINT: While overall demand has lagged expectations, higher-priced iPhone 14 Pro models appear to attract more attention than entry-level versions, sources said Apple Inc is backing off plans to increase production of its new iPhones this year after an anticipated surge in demand failed to materialize, people familiar with the matter said. The Cupertino, California-based company has told suppliers to pull back from efforts to increase assembly of the iPhone 14 product family by as many as 6 million units in the second half of this year, said the people, asking not to be named as the plans are not public. Instead, the company would aim to produce 90 million handsets for the period, about the same level as in the second half
RSS